Thursday, June 20, 2019
Denise Landry

A team of experts gathered by the International Collaboration for Transfusion Medicine Guidelines has developed new clinical guidelines and accompanying patient and physician resources for Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) – a potentially devastating illness in fetuses and newborns.

Tuesday, June 25, 2019
Jenny Ryan

A new publication in CMAJ (Canadian Medical Association Journal) aims to help health care teams navigate clinical issues surrounding organ and tissue donation by patients who choose to donate after medical assistance in dying (MAID) or withdrawal of life-sustaining measures. In collaboration with...

Tuesday, June 11, 2019
Bronwyn Lyons

The Centre for Blood Research’s symposium was held in Vancouver, British Columbia in April. Featuring talks from world-class researchers, trainees and patients, the Norman Bethune Symposium provided attendees with the perfect blend of information and inspiration.

Thursday, June 06, 2019
Stefanie Novakowski

The ability to genetically modify a cell is a powerful tool. Genetically modified cells have advanced our understanding of how the body works and how diseases develop. They are currently used to treat a range of diseases, from cancers to bleeding disorders. Yet, not all cells are easily modified. Dr. Stefanie Novakowski’s joint 3rd place entry to our Lay Science Writing Competition explains more.